Court Tosses Shareholders’ Lawsuit Against Synthes

A Delaware Chancery Court judge dismissed allegations that Synthes did not patiently shop or gain the highest price for Johnson & Johnson’s $21.3 billion acquisition of the company, according to a Bloomberg Businessweek report.

Advertisement

Synthes shareholders filed a lawsuit against the company, claiming it made the transaction to quickly come up with funds for Synthes chairman and controlling shareholder Hansjoerg Wyss’ retirement.

Judge Leo Strine tossed out these allegations, citing lack of evidence to support their accusations.

More Articles on Orthopedic Devices:

FH Orthopedics Wins FDA Approval for Complete Shoulder Prosthesis System

5 More Things to Know About Spine Surgery

Johnson & Johnson Recalls All Unused Custom Orthopedic Implants

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.